Sustainability is becoming a key part of healthcare decision-making. At Asc Academics, we help quantify and communicate the environmental impact of pharmaceuticals, translating complex data into clear insights that support market access, payer discussions and broader value strategies.
Lifecycle assessment
Our sustainability experts conduct comprehensive life cycle assessments (LCAs) to measure the environmental footprint of pharmaceutical products. We assess emissions across the full product lifecycle, from manufacturing to disposal, ensuring alignment with international standards such as ISO 14044/67, PAS 2050 and the GHG Protocol.
Head-to-head carbon footprint comparison
We go beyond standalone assessments by enabling direct, publishable product comparisons. Without requiring competitor data, our approach provides head-to-head carbon footprint analyses, helping demonstrate your product’s environmental performance in payer and market access discussions.
Carbon reporting
We support transparent and reliable carbon reporting in line with global frameworks such as CDP and SBTi. Our work ensures compliance while integrating sustainability into both corporate and product-level value communication.
Sustainability impact assessment (ESG)
Using leading frameworks such as ESG, Impact-Weighted Accounting and the Capitals Approach, we assess the broader environmental, social and economic impact of your product. These insights strengthen market access, HTA submissions and sustainability narratives across stakeholders.